Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy
NCT00113620 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2016-07-14
Summary
The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.
Conditions
- Pain
- Diabetic Neuropathy
Interventions
- DRUG
-
Neurodex
Sponsors & Collaborators
-
Avanir Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
- Primary Completion
- 2007-02-28
- Completion
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
NCT01035281 ·Status: UNKNOWN ·Phase: PHASE3
-
Topical Menthol +/- Mannitol for Painful Diabetic Peripheral Neuropathy
NCT02728687 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
NCT01086150 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT04688671 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy
NCT02643251 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy
NCT00695565 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Neuropathy Topical Treatment
NCT00661063 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy
NCT00993018 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy
NCT01521598 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01345045 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00548925 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for the Treatment of Painful Diabetic Neuropathy
NCT00058968 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00507936 ·Status: COMPLETED ·Phase: PHASE2
-
Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy
NCT03050827 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04455633 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
NCT00837941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability
NCT01928381 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT01496365 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN
NCT04857957 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
NCT04469270 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China
NCT00408993 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT03219320 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy
NCT04106050 ·Status: WITHDRAWN ·Phase: PHASE1
-
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
NCT00476931 ·Status: COMPLETED ·Phase: PHASE2